Post-transfusion parasite transmission: Do the present controls fit with the EU directive?;Le risque parasitaire transfusionnel: Quels contrôles au regard de la directive européenne?

Transfusion Clinique et Biologique

Volumn 12, Issue 3, 2005, Pages 275-285

  Garraud, O ^a,b   Elghouzzi, M H ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

Author keywords

Adverse effects; Chagas disease; Hemovigilance; Parasites; Transfusion; Trypanosomiasis

Indexed keywords

BACTERIAL TRANSMISSION; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CONTROL; EUROPE; HUMAN; INFECTION RISK; PARASITE TRANSMISSION; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; SAFETY; VIRUS TRANSMISSION;

EID: 22144480966     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2005.05.001     Document Type: Short Survey

References (42)

1. K. Janatpour, and P.V. Holland Noninfectious serious hazards of transfusion Curr. Hematol. Rep. 1 2002 149 155
2. K.E. Webert, and M.A. Blajchman Transfusion-related acute lung injury Transfus. Med. Rev. 17 2003 252 262
3. G.E. Tegtmeier Infectious diseases transmitted by transfusion: a miscellanea Vox Sang. 67 1994 S179 S181
4. M.A. Blajchman Bacterial contamination of cellular blood components: risks, sources and control Vox Sang. 87 2004 98 103
5. O. Garraud Agents transmissibles non conventionnels et virus (et autres pathogènes infectieux) émergents Transfus. Clin. Biol. 10 2003 238 243
6. J.P. Allain Transfusion risks of yesterday and today Transfus. Clin. Biol. 10 2003 1 5
7. J.P. Allain, M. Anokwa, and A. Casbard Sociology and behaviour of West-African blood donors: the impact of religion on human immunodeficency virus infection Vox Sang. 87 2004 233 240
8. S.M. Bird Attributable testing for abnormal prion protein, database linkage, and blood-borne vCJD risks Lancet 364 2004 1362 1364
9. S. Wendel Current concepts on transmission of bacteria and parasites by blood components Vox Sang. 67 1994 S3 S4
10. P. Rouger Du paludisme au paludisme post-transfusionnel Transfus. Clin. Biol. 6 1999 72 74
11. F. Bruneel, M. Thellier, and O. Eloy Transfusion-transmitted malaria Intensive Care Med. 30 2004 1851 1852
12. M.S. Fereira, and A.S. Borges Some aspects of protozoan infections in immunocompromised patients - a review Mem. Oswaldo Cruz 97 2002 443 457
13. M. Recker, S. Nee, and P. Bull Transient cross-reactive immune responses can orchestrate antigenic variation in malaria Nature 429 2004 555 558
14. D. Doolan, S. Southwood, and D.A. Freilich Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data Proc. Natl. Acad. Sci. USA 100 2003 9952 9957
15. R.G. Cable, and D.A. Leiby Risk and prevention of transfusion-transmitted babesiosis an other tick-borne diseases Curr. Opin. Hematol. 10 2003 405 411
16. E.R. Bregani, L. Balzarini, C. Ghiringhelli, and P. Tarsia Transfusional Mansonella perstans microfilariasis Parassitologia 45 2003 71 72
17. Y. Le Fichoux, J.-F. Quaranta, and J.-P. Aufeuvre Occurrence of Leishmania infantum parasitaemia in asymptomatic blood donors living in an area of endemicity in Southern France J. Clin. Microbiol. 37 1999 1953 1957
18. P. Mathur, and J.C. Samantaray The first probable case of platelet transfusion-transmitted visceral leishmaniasis Transfus. Med. 14 2004 319 321
19. T.B. Lathia, and R. Joshi Can hematological parameters discriminate malaria from nonmalarious acute febrile illnes in the tropics? Indian J. Med. Sci. 58 2004 239 244
20. J. Pillonel, and S. Laperche [Trends in residual risk of transfusion-trnasmitted viral infections (HIV, HCV, HBV) in France, between 1992 and 2002, and impact of the viral genome screening (nuclear acid testing)] Transfus. Clin. Biol. 11 2004 81 86
21. H.W. Reesink, and C.P. Engelfriet Are current measures to prevent transfusion-associated protozoa infections sufficient? Vox Sang. 87 2004 125 138
22. O. Garraud, J. Relave, P. Flori, and R. Perraut Le risque de paludisme transfusionnel confronté à celui de la mutité biologique: deux données irréconciliables? Transfus. Clin. Biol. 11 2004 87 94
23. M.A. Winkler, R.J. Brashear, and H.J. Hall Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United State. II Evaluation of asupplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivity Transfusion 35 1995 219 225
24. C. Aznar, P. Liegeard, and C. Mariette A simple Trypanosoma cruzi enzyme-linked immunoassay for control of human infection in nonendemic areas FEMS Immunol. Med. Microbiol. 18 1997 31 37
25. E.S. Umezawa, and J.E. Silveira Serological diagnosis of Chagas disease with prified and Trypanosoma cruzi antigens Mem. Oswaldo Cruz S1 1999 285 288
26. E. Umezawa, S.F. Bastos, and J.R. Coura An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens Transfusion 43 2003 91 97
27. E.P. Silveira-Lacendra, A.G. Silva, and S.F. Junior Chagas' disease: application of TESA-blot in inconclusive sera from a Brasilian blood bank Vox Sang. 87 2004 204 207
28. O.A. Salomone, A.L. Basquiera, and A. Sembaj Trypanosoma cruzi in persons without serological evidence of disease, Argentina Emerging Infect. Dis 9 2003 1558 1562
29. M.L. Gomes, A.M. Macedo, and A.R. Vago Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood Exp. Parasitol. 88 1998 28 33
30. WHO Informal consultation on recent advances in Diagnostic Techniques and Vaccines for malaria A rapid dipstick antigen capture assay for the diagnosis of malaria WHO Bulletin 74 1996 45 54
31. O. Silvie, M. Theillier, and M. Rosenheim Potential value of Plasmodium falciparum-associated antigen and antibody detection for screening of blood donors to prevent transfusion-transmitted malaria Transfusion 42 2002 357 362
32. TM-F-test in the diagnosis of Plasmodium falciparum malaria Med. Sci. Monit. 10 2004 MT81 MT88
33. A.D. Kitchen, P.H. Lowe, K. Lalloo, and P.L. Chiodini Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical use Vox Sang. 87 2004 150 155
34. C.P. Soler, P. Gerome, and B. Soullie [Comparisons of techniques used to screen blood donations for malaria antibodies] Med. Trop 63 2003 587 589
35. O. Garraud, M.-H. Elghouzzi, and S. Laperche Revision of the measures to prevent transfusion-associated protozoal infections in Metropolitan and Overseas France J Travel Med Infect Dis 2005 (in press)
36. Directive 2004/33/CE de la Commission du 22 mars 2004 portant application de la directive 2002/98/CE du Parlement Européen et du Conseil concernant certaines exigences techniques relatives au sang et aux composants sanguins. Journal Officiel de l'Union Européenne, 30. 3. 04. L.91/25-39.
37. D. Filisetti, S. Bombard, and C. N'Guiri Prospective assessment of a new polymerase chain reaction target (STEVOR) for imported Plasmodium falciparum malaria Eur. J. Clin. Microb. Infect. Dis. 21 2002 679 681
38. B. Carme, I. Aune, and C. Aznar Four cases of acute chagasic myocarditis in French Guiana Am. J. Trop. Med. Hyg. 64 2001 162 163
39. Concile of Europe Guide to the preparation, use and quality assurance of blood components - 11th Edition 2005 (250 pp)
40. L. Corash Inactivation of infectious pathogens in labile blood components: meeting the challenge Transfus. Clin. Biol. 8 2001 138 145
41. T.G. Smith, and K.C. Kain Inactivation of Plasmodium falciparum by photodynamic excitation of heme-cycle intermediates derived from delta-aminolevulinic acid J. Infect. Dis. 190 2004 184 191
42. B. Zavizion, M. Pereira, and J. Milena de Melo Inactivation of protozoan parasites in red blood cells using InactinePen110 chemistry Transfusion 44 2004 731 738